{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:48:42Z","timestamp":1781333322397,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Centre of Postgraduate Medical Education in Warsaw","award":["501-1-21-27-18"],"award-info":[{"award-number":["501-1-21-27-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>Assessment of the maternal complications in molecularly confirmed diandric and digynic triploid pregnancies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Sonographic features, biochemical results, and clinical presentation were analyzed. Beta-hCG level was controlled after diandric triploidy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The study included nine diandric and twelve digynic triploid pregnancies at the mean gestational age at diagnosis of 14.9 and 18.0 weeks, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.0391). Mean value of total-hCG was 979 703.6 U\/ml in diandric cases and 5 455.4 U\/ml in digynic ones (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.000). Maternal complications occurred in 88.9% of diandric triploid pregnancies, including: thecalutein cysts (44.4%), hyperemesis gravidarum (44.4%), symptomatic hyperthyreosis (33.3%), early onset gestational hypertension (22.2%) and vaginal bleeding (11.1%). No case of proteinuria, preeclampsia or HELLP syndrome was observed. Only maternal complication observed in digynic triploidy was vaginal bleeding (50.0%). The mean time of beta-hCG normalization after diandric triploid pregnancies was 84 days (range 11\u2013142 days). No case of gestational trophoblastic neoplasia (GTN) was observed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Maternal complications (except for vaginal bleeding) are associated with diandric triploidy. The relatively low incidence of hypertensive maternal complications and their less severe course in our cohort may be attributed to the earlier prenatal diagnosis. The frequency of GTN after diandric triploidy may be lower than previously reported.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00404-020-05515-4","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:02:53Z","timestamp":1585220573000},"page":"1139-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Maternal complications in molecularly confirmed diandric and digynic triploid pregnancies: single institution experience and literature review"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-6388","authenticated-orcid":false,"given":"D.","family":"Massalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bijok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kuci\u0144ska-Chahwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Zimowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ozdarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Raniszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Panek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Roszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"5515_CR1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/01443615.2011.598966","volume":"31","author":"I Anev","year":"2011","unstructured":"Anev I, Rajasri AG, Reddy K, Pillai M (2011) Triploidy without molar change presenting as severe pre-eclampsia and left ventricular failure at 15 weeks. J Obstet Gynaecol 31:659\u2013660","journal-title":"J Obstet Gynaecol"},{"issue":"7","key":"5515_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/14767050600553084","volume":"19","author":"MJ Barsoom","year":"2006","unstructured":"Barsoom MJ, McEntaffer A, Fleming A, Nipper HC (2006) Marked abnormal quadruple screen in a patient with severe preeclampsia at 20 weeks with a triploid fetus. J Matern Fetal Neonatal Med 19(7):443\u2013444","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5515_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bmj.3.5563.476","volume":"3","author":"NA Beischer","year":"1967","unstructured":"Beischer NA, Fortune DW, Fitzgerald MD (1967) Hydatidiform mole and coexistent fetus, both with triploid chromosome constitution. Br Med I 3:476","journal-title":"Br Med I"},{"key":"5515_CR4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/uog.1015","volume":"23","author":"MH Billieux","year":"2004","unstructured":"Billieux MH, Petignat P, Fior A et al (2004) Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes. Ultrasound Obstet Gynecol 23:398\u2013401","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5515_CR5","first-page":"223","volume":"28","author":"FF Broekhuizen","year":"1983","unstructured":"Broekhuizen FF, Elejalde R, Hamilton PR (1983) Early-onset preeclampsia, triploidy and fetal hydrops. J Reprod Med 28:223\u2013226","journal-title":"J Reprod Med"},{"key":"5515_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0020-7292(83)90054-1","volume":"21","author":"MS Chatterjee","year":"1983","unstructured":"Chatterjee MS, Tejani NA, Vema UL et al (1983) Prenatal diagnosis of triploidy. Int J Gynecol Obstet 21:155","journal-title":"Int J Gynecol Obstet"},{"key":"5515_CR7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/cncr.20107","volume":"100","author":"ANY Cheung","year":"2004","unstructured":"Cheung ANY, Khoo US, Lai CYL et al (2004) Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole. Cancer 100:1411\u20131417","journal-title":"Cancer"},{"key":"5515_CR8","first-page":"103","volume":"13","author":"SM Cox","year":"1993","unstructured":"Cox SM, Klein VR (1993) Partial molar pregnancy associated with severe pregnancy-induced hypertension. J Perinat 13:103\u2013106","journal-title":"J Perinat"},{"issue":"2","key":"5515_CR9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.12.008","volume":"148","author":"C Coyle","year":"2018","unstructured":"Coyle C, Short D, Jackson L et al (2018) What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. Gynecol Oncol 148(2):254\u2013257","journal-title":"Gynecol Oncol"},{"key":"5515_CR10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1067\/mob.2000.103771","volume":"182","author":"K Craig","year":"2000","unstructured":"Craig K, Pinette MG, Blackstone J, Chard R, Cartin A (2000) Highly abnormal maternal inhibin and \u03b2-human chorionic gonadotropin levels along with severe HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome at 17 weeks\u2019 gestation with triploidy. Am J Obstet Gynecol 182:737\u2013739","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/pd.164","volume":"21","author":"A Daniel","year":"2001","unstructured":"Daniel A, Wu Z, Bennetts B et al (2001) Karyotype, phenotype and parental origin in 19 cases of triploidy. Prenat Diagn 21:1034\u20131048","journal-title":"Prenat Diagn"},{"key":"5515_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000129932","volume":"6","author":"JH Edwards","year":"1967","unstructured":"Edwards JH, Yuncken C, Rushton DJ, Richards S, Mittwoch U (1967) Three cases of triploidy in man. Cytogenetics 6:81","journal-title":"Cytogenetics"},{"key":"5515_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-008-0732-2","volume":"279","author":"A Falkert","year":"2009","unstructured":"Falkert A, Yildiz A, Seelbach- Goebel B (2009) Partial mole with fetal triploidy as a cause for imminent HELLP-syndrome at 16 weeks of gestation. Arch Gynecol Obstet 279:423\u2013425","journal-title":"Arch Gynecol Obstet"},{"key":"5515_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pd.1970040704","volume":"4","author":"MA Fergusson-Smith","year":"1984","unstructured":"Fergusson-Smith MA, Yates JRW (1984) Maternal age specific rates for chromosomal aberrations and factors influencing them: report of collaborative European study on 52,965 amniocenteses. Prenat Diagn 4:5\u201344","journal-title":"Prenat Diagn"},{"key":"5515_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/pd.1970090606","volume":"9","author":"JM Graham","year":"1989","unstructured":"Graham JM, Rawnsley EF, Millard-Simmons G (1989) Triploidy: pregnancy complications and clinical findings in seven cases. Prenat Diagn 9:409\u2013419","journal-title":"Prenat Diagn"},{"key":"5515_CR16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0002-9378(73)91028-4","volume":"116","author":"JS Hashimoto","year":"1973","unstructured":"Hashimoto JS, Ling SH, Millerick JD, Kelley DJ (1973) Mid-trimester preeclampsia associated with fetal triploidy: report of a case. Am J Obstet Gynecol 116:882\u2013883","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergen.2012.01.004","volume":"205","author":"L Hoffner","year":"2012","unstructured":"Hoffner L, Surti U (2012) The genetics of gestational trophoblastic disease: a rare complication of pregnancy. Cancer Genet 205:63\u201377","journal-title":"Cancer Genet"},{"key":"5515_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1469-1809.1982.tb00714.x","volume":"46","author":"PA Jacobs","year":"1982","unstructured":"Jacobs PA, Szulman AE, Funkhouser J et al (1982) Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet 46:223\u2013231","journal-title":"Ann Hum Genet"},{"key":"5515_CR19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0029-7844(96)00330-4","volume":"88","author":"E Jauniaux","year":"1996","unstructured":"Jauniaux E, Brown R, Rodeck C, Nicolaides KH (1996) Prenatal diagnosis of triploidy during the second trimester of pregnancy. Obstet Gynecol 88:983\u2013989","journal-title":"Obstet Gynecol"},{"key":"5515_CR20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9378(97)70546-5","volume":"176","author":"E Jauniaux","year":"1997","unstructured":"Jauniaux E, Brown R, Snijders RJM et al (1997) Early prenatal diagnosis of triploidy. Am J Obstet Gynecol 176:550\u2013554","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR21","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2014.03.039","volume":"211","author":"MW Joergensen","year":"2014","unstructured":"Joergensen MW, Niemann I, Rasmussen AA et al (2014) Triploid pregnancies: genetic and clinical features of 158 cases. Am J Obstet Gynecol 211:370.e1\u201319","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/pd.2149","volume":"28","author":"KO Kagan","year":"2008","unstructured":"Kagan KO, Anderson JM, Anwandter G, Neksasova K, Nicolaides KH (2008) Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Prenat Diagn 28:1209\u20131213","journal-title":"Prenat Diagn"},{"key":"5515_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0002-9378(79)90422-8","volume":"133","author":"PE Lewis","year":"1979","unstructured":"Lewis PE, Cefalo RC (1979) Triploidy syndrome with theca lutein cysts and severe preeclampsia. Am J Obstet Gynecol 133:110\u2013111","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"5515_CR24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/humrep\/13.8.2082","volume":"13","author":"M Ludwig","year":"1998","unstructured":"Ludwig M, Gembruch U, Bauer O, Diedrich K (1998) Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod 13(8):2082\u20132087","journal-title":"Hum Reprod"},{"key":"5515_CR25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00216452","volume":"92","author":"DE McFadden","year":"1993","unstructured":"McFadden DE, Kwong LC, Yam IYL, Langlois S (1993) Parental origin of triploidy in human fetuses: evidence for genomic imprinting. Hum Genet 92:465\u2013469","journal-title":"Hum Genet"},{"key":"5515_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.1971.tb00247.x","volume":"78","author":"WG Paterson","year":"1971","unstructured":"Paterson WG, Hobson BM, Smart GE, Bain AD (1971) Two cases of hydatidiform degeneration of the placenta with fetal abnormality and triploid chromosome constitution. J Obstet Gynecol Br Commonw 78:136","journal-title":"J Obstet Gynecol Br Commonw"},{"key":"5515_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7863\/jum.1989.8.9.507","volume":"8","author":"RA Pircon","year":"1989","unstructured":"Pircon RA, Porto M, Towers CV, Crade M, Gocke SE (1989) Ultrasound findings in pregnancies complicated by fetal triploidy. J Ultrasound Med 8:507\u2013511","journal-title":"J Ultrasound Med"},{"key":"5515_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1479-828X.2000.tb01152.x","volume":"40","author":"F Rahimpanah","year":"2000","unstructured":"Rahimpanah F, Smoleniec J (2000) Partial mole, triploidy and proteinuric hypertension: two case reports. Aust N Z J Obstet Gynaecol 40:215\u2013218","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"5515_CR29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0029-7844(97)00540-1","volume":"90","author":"A Rijhsinghani","year":"1997","unstructured":"Rijhsinghani A, Yankowitz J, Strauss RA, Kuller JA, Patil S, Williamson RA (1997) Risk of preeclampsia in second-timester triploid pregnancies. Obstet Gynecol 90:884\u2013888","journal-title":"Obstet Gynecol"},{"key":"5515_CR30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000130082","volume":"9","author":"AM Schindler","year":"1970","unstructured":"Schindler AM, Mikamo K (1970) Triploidy in man. Cytogenetics 9:116","journal-title":"Cytogenetics"},{"issue":"11","key":"5515_CR31","doi-asserted-by":"crossref","first-page":"e0142545","DOI":"10.1371\/journal.pone.0142545","volume":"10","author":"NB Scholz","year":"2015","unstructured":"Scholz NB, Bolund L, Nyegaard M et al (2015) Triploidy\u2014observations in 154 diandric cases. PLoS ONE 10(11):e0142545","journal-title":"PLoS ONE"},{"key":"5515_CR32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","volume":"356","author":"MJ Seckl","year":"2000","unstructured":"Seckl MJ, Fisher RA, Salerno G et al (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356:36\u201339","journal-title":"Lancet"},{"key":"5515_CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2006-934093","volume":"23","author":"DM Sherer","year":"2006","unstructured":"Sherer DM, Dalloul M, Stimphil R et al (2006) Acute onset of severe hemolysis, elevated liver enzymes, and low platelet count syndrome in a patient with a partial hydatidiform mole at 17 weeks gestation. Am J Perinatol 23:163\u2013166","journal-title":"Am J Perinatol"},{"key":"5515_CR34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9378(76)90652-9","volume":"126","author":"BJ Sicuranza","year":"1976","unstructured":"Sicuranza BJ, Tisdall LH (1976) Hydatidiform mole and eclampsia with coexisting living fetus in the second trimester of pregnancy. Am J Obstet Gynecol 126:513","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/0002-9378(93)90452-O","volume":"169","author":"MA Slattery","year":"1993","unstructured":"Slattery MA, Khong TY, Dawkins RR, Pridmore BR, Hague WM (1993) Eclampsia in association with partial molar pregnancy and congenital abnormalities. Am J Obstet Gynecol 169:1625\u20131627","journal-title":"Am J Obstet Gynecol"},{"key":"5515_CR36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00007611-199511000-00012","volume":"88","author":"KA Sorem","year":"1995","unstructured":"Sorem KA, Shah DM (1995) Advanced triploid pregnancy and preeclampsia. South Med J 88:1144\u20131145","journal-title":"South Med J"},{"key":"5515_CR37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1469-0705.2002.00822.x","volume":"20","author":"T Stefos","year":"2002","unstructured":"Stefos T, Plachouras N, Mari G, Cosmi I, Lolis D (2002) A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks\u2019 gestation. Ultrasound Obstet Gynecol 20:403\u2013404","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"5515_CR38","first-page":"QD01","volume":"9","author":"I Uzun","year":"2015","unstructured":"Uzun I, Pata O, Unlu C, Tokat F, Ozdemir M (2015) Uncommon presentation of triploidy: a case report. J Clin Diagn Res 9(10):QD01\u2013QD02","journal-title":"J Clin Diagn Res"},{"key":"5515_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jmg.10.2.135","volume":"10","author":"S Walker","year":"1973","unstructured":"Walker S, Andrews J, Gregson NM, Gault W (1973) Three further cases of triploidy in man surviving to birth. J Med Genet 10:135\u2013141","journal-title":"J Med Genet"},{"key":"5515_CR40","first-page":"69","volume":"47","author":"W Wertelecki","year":"1976","unstructured":"Wertelecki W, Graham JM, Sergovich FR (1976) The clinical syndrome of triploidy. Obstet Gynecol 47:69\u201376","journal-title":"Obstet Gynecol"},{"key":"5515_CR41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/01443610701325770","volume":"27","author":"LFA Wong","year":"2007","unstructured":"Wong LFA, Stuart B, Gleeson N (2007) Triploidy partial mole and proteinuric hypertension. J Obstet Gynaecol 27:424\u2013425","journal-title":"J Obstet Gynaecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-020-05515-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:32:24Z","timestamp":1616718744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-020-05515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5515"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05515-4","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All performed procedures were in accordance with the ethical standards of the Bioethics Committee of the Centre of Postgraduate Medical Education in Warsaw (Approval No. 82\/PB\/2017) and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}